Gyeonggi Province Integrates AI into Healthcare... Establishes Diagnostic System and Data Platform

Gyeonggi Province will establish an artificial intelligence (AI)-powered diagnostic system and data platform at three Gyeonggi Provincial Medical Centers.

On May 12, Gyeonggi Province announced that it had selected the YusinCNC Consortium as the final implementing agency for the "2025 Gyeonggi AI Public Healthcare Demonstration Support Project." The province will introduce an "AI diagnostic assistance system" and a "medical imaging AI data platform" at three public medical centers under the Gyeonggi Provincial Medical Center: Suwon, Anseong, and Icheon.

The AI diagnostic assistance system is a project that links the medical institution's Picture Archiving and Communication System (PACS) with AI for use in real-time clinical practice. It will support image interpretation for major diseases such as lung nodules, breast cancer, dementia, and stroke, as well as solutions certified by the Ministry of Food and Drug Safety. By assisting medical staff with image interpretation, the system is expected to improve both the accuracy and speed of diagnoses.

The medical imaging AI data platform is a system designed to systematically manage and utilize medical imaging data. It will collect and integrate imaging data from the three medical centers and convert it into AI training data, helping to address the difficulties that medical AI companies face in securing data.

This demonstration project will run for approximately seven months, until November. At the end of the project, Gyeonggi Province will hold a results-sharing session to present the outcomes of system operations and cases of medical data utilization. Based on the demonstration results, the province will consider expanding the project and reflect the findings in future Gyeonggi AI healthcare policies.

Gyeonggi Provincial Medical Center is launching a project to build diagnostic services and a data platform using AI. Provided by Gyeonggi Province

Kim Kibyeong, Director of AI at Gyeonggi Province, stated, "Through this AI public healthcare support project, we will fully initiate the AI transformation of public healthcare sites," adding, "We will do our utmost to enhance the quality of public healthcare services using AI and to strengthen the medical AI ecosystem based on the integration of AI and public healthcare data."

The YusinCNC Consortium participating in the demonstration project consists of YusinCNC as the lead organization, joined by domestic medical AI and medical imaging specialist companies such as Lunit, Hurayon, PurpleAI, Infinite Healthcare, and Monitor Corporation.

YusinCNC is a company specializing in image transmission, with strengths in PACS integration and image data pseudonymization (a data de-identification technique that maintains data utility while enhancing personal information protection). Lunit possesses world-class AI diagnostic solutions in the fields of lung nodules and breast cancer.

Hurayon specializes in MRI-based analysis technology focused on brain diseases, while PurpleAI excels in CT-based brain disease diagnosis. Monitor Corporation supplies AI solutions with high accuracy in lung cancer diagnosis, and Infinite Healthcare, the market leader in Korea's PACS sector, has expertise in integrated data management.

The consortium will designate Anseong Medical Center as the base center and operate an integrated diagnostic assistance system in connection with Suwon and Icheon Medical Centers.

This content was produced with the assistance of AI translation services.